5-1279370-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP5BP4
The NM_198253.3(TERT):c.2051A>G(p.Asp684Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000715 in 1,567,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D684D) has been classified as Likely benign.
Frequency
Consequence
NM_198253.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TERT | NM_198253.3 | c.2051A>G | p.Asp684Gly | missense_variant | 5/16 | ENST00000310581.10 | NP_937983.2 | |
TERT | NM_001193376.3 | c.2051A>G | p.Asp684Gly | missense_variant | 5/15 | NP_001180305.1 | ||
TERT | NR_149162.3 | n.2130A>G | non_coding_transcript_exon_variant | 5/13 | ||||
TERT | NR_149163.3 | n.2130A>G | non_coding_transcript_exon_variant | 5/13 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152094Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000158 AC: 27AN: 170622Hom.: 0 AF XY: 0.000162 AC XY: 15AN XY: 92552
GnomAD4 exome AF: 0.0000664 AC: 94AN: 1415304Hom.: 0 Cov.: 33 AF XY: 0.0000686 AC XY: 48AN XY: 700184
GnomAD4 genome AF: 0.000118 AC: 18AN: 152094Hom.: 0 Cov.: 34 AF XY: 0.000202 AC XY: 15AN XY: 74298
ClinVar
Submissions by phenotype
Dyskeratosis congenita, autosomal dominant 2;C3553617:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Degerman lab, Umeå University | Nov 23, 2017 | - - |
Dyskeratosis congenita Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 08, 2024 | Variant summary: TERT c.2051A>G (p.Asp684Gly) results in a non-conservative amino acid change located in the Reverse transcriptase domain (IPR000477) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 7.1e-05 in 1567398 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in TERT causing Dyskeratosis congenita, however the frequency in the Finnish subpopulation was 0.0018 in 59326 control chromosomes. These data allow no conclusion about variant significance but may suggest a possible founder effect among individuals of Finnish descent. c.2051A>G has been reported in the literature in the compound heterozygous or homozygous state in multiple Finnish/Nordic individuals affected with clinical features of Dyskeratosis congenita and related telomere biology disorders (example, Norberg_2018, Trotta_2018) and in the heterozygous state in multiple individuals with familial pulmonary fibrosis and/or interstitial lung disease (example, Liu_2023, Stark_2022). These data indicate that the variant is very likely to be associated with autosomal recessive disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 36622818, 29483670, 35083318, 30115091). ClinVar contains an entry for this variant (Variation ID: 446372). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Dyskeratosis congenita, autosomal dominant 2;C5561926:Interstitial lung disease 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 31, 2021 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Dec 19, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at